Some remarks on Fitzpatrick and Flynn's Gröbner basis technique for Padé approximation
John B. Little , David Ortiz , Ricardo Ortiz-Rosado , Rebecca Pablo
Journal of Symbolic Computation 35 ( 4) 451 -461
2
2003
Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K ATP channel
Petra Kühner , Renate Prager , Damian Stephan , Ulrich Russ
Naunyn-schmiedebergs Archives of Pharmacology 385 ( 3) 299 -311
17
2012
Role of the amino-terminal transmembrane domain of sulfonylurea receptor SUR2B for coupling to K IR 6.2, ligand binding, and oligomerization
Marcus Winkler , Petra Kühner , Ulrich Russ , David Ortiz
Naunyn-schmiedebergs Archives of Pharmacology 385 ( 3) 287 -298
7
2012
Two Neonatal Diabetes Mutations on Transmembrane Helix 15 of SUR1 Increase Affinity for ATP and ADP at Nucleotide Binding Domain 2
David Ortiz , Peter Voyvodic , Lindsay Gossack , Ulrich Quast
Journal of Biological Chemistry 287 ( 22) 17985 -17995
21
2012
Neonatal diabetes and congenital hyperinsulinism caused by mutations in ABCC8/SUR1 are associated with altered and opposite affinities for ATP and ADP
David Ortiz , Joseph Bryan
Frontiers in Endocrinology 6 48 -48
6
2015
Walker-A Motif Acts to Coordinate ATP Hydrolysis with Motor Output in Viral DNA Packaging
Damian delToro , David Ortiz , Mariam Ordyan , Jean Sippy
Journal of Molecular Biology 428 ( 13) 2709 -2729
16
2016
Functional Dissection of a Viral DNA Packaging Machine's Walker B Motif.
Damian delToro , David Ortiz , Mariam Ordyan , Joshua Pajak
Journal of Molecular Biology 431 ( 22) 4455 -4474
7
2019
CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins
Guo Zhong , David Ortiz , Alex Zelter , Abhinav Nath
Molecular Pharmacology 93 ( 5) 489 -503
12
2018
Reinterpreting the Action of ATP Analogs on KATP Channels
David Ortiz , Lindsay Gossack , Ulrich Quast , Joseph Bryan
Journal of Biological Chemistry 288 ( 26) 18894 -18902
23
2013
Comparing Antibody-Antigen Binding in Serum Versus Buffer with Fluorescence Correlation Spectroscopy
David Ortiz , Isabel Yannatos , Abhinav Nath
Biophysical Journal 112 ( 3) 150
2017
Physical and Functional Characterization of a Viral Genome Maturation Complex
Teng-Chieh Yang , David Ortiz , Qin Yang , Rolando W. De Angelis
Biophysical Journal 112 ( 8) 1551 -1560
8
2017
Biochemical and kinetic characterization of CYP26C1 in retinoic acid and 4-OXO-all-trans-retinoic acid metabolism
Guo Zhong , David Ortiz , Jay Kirkwood , Alex Zelter
Drug Metabolism and Pharmacokinetics 33 ( 1)
2018
Spinal implant device
Jason Blain , David Hart , Dean Johnson , Gregory Martin
13
2022
Development of a topoisomerase 1 inhibitor platform technology for efficacious and well tolerated ADCs
Ryan Lyski , Lauren Bou , Johann Sigurjonsson , David Meyer
Cancer Research 84 ( 6_Supplement) 5733 -5733
2024
Evidence that a catalytic glutamate and an ‘Arginine Toggle’ act in concert to mediate ATP hydrolysis and mechanochemical coupling in a viral DNA packaging motor
David Ortiz , Damian delToro , Mariam Ordyan , Joshua Pajak
Nucleic Acids Research
15
2018
SGN-ALPV a novel, investigational vedotin ADC demonstrates highly effective targeting of oncofetal phosphatases ALPP and ALPPL2 in preclinical models
Sarah Anderson , Nanna Hansen , Robert Lawrence , Aroon T Chande
Cancer Research 82 ( 12_Supplement) 1766 -1766
1
2022
Utilizing PDX models to better understand factors that predict response to SGN-CD228A, an antibody drug-conjugate (ADC) for solid tumors
Sharsti Sandall , Rebecca Mazahreh , Marsha Mason , John Gosink
Cancer Research 80 ( 16_Supplement) 2888 -2888
2020
Discovery of a tripeptide-based camptothecin drug-linker for antibody-drug conjugates with potent antitumor activity and a broad therapeutic window
Ryan Lyski , Lauren Bou , Margo Zaval , Kim Emmerton
Cancer Research 80 ( 16_Supplement) 2885 -2885
4
2020
Abstract C113: Discovery of a novel auristatin antibody drug conjugate drug linker with equal efficacy and reduced bone marrow toxicity compared to vedotin
Noah A Bindman , Roma Yumul , Erica E McKinney , Scott Blackburn
Molecular Cancer Therapeutics 22 ( 12_Supplement) C113 -C113
2023
Retractor
David Ortiz , Kyle Elsabee , Jason Blain , Tyson Vogel
25
2021